{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:54:05Z","timestamp":1792292045981,"version":"4.4.0"},"reference-count":330,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Acquiring the recommended daily allowance of vitamins is crucial for maintaining homeostatic balance in humans and other animals. A deficiency in or dysregulation of vitamins adversely affects the neuronal metabolism, which may lead to neurodegenerative diseases. In this article, we discuss how novel vitamin-based approaches aid in attenuating abnormal neuronal functioning in neurodegeneration-based brain diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, Amyotrophic lateral sclerosis, and Prion disease. Vitamins show their therapeutic activity in Parkinson\u2019s disease by antioxidative and anti-inflammatory activity. In addition, different water- and lipid-soluble vitamins have also prevented amyloid beta and tau pathology. On the other hand, some results also show no correlation between vitamin action and the prevention of neurodegenerative diseases. Some vitamins also exhibit toxic activity too. This review discusses both the beneficial and null effects of vitamin supplementation for neurological disorders. The detailed mechanism of action of both water- and lipid-soluble vitamins is addressed in the manuscript. Hormesis is also an essential factor that is very helpful to determine the effective dose of vitamins. PubMed, Google Scholar, Web of Science, and Scopus were employed to conduct the literature search of original articles, review articles, and meta-analyses.<\/jats:p>","DOI":"10.3390\/biomedicines9101284","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T09:14:57Z","timestamp":1632302097000},"page":"1284","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["The Role of Vitamins in Neurodegenerative Disease: An Update"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-9549","authenticated-orcid":false,"given":"Sachchida Nand","family":"Rai","sequence":"first","affiliation":[{"name":"Centre of Biotechnology, University of Allahabad, Prayagraj 211002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Zoology, MMV, Banaras Hindu University, Varanasi 221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-0604","authenticated-orcid":false,"given":"Harry W.M.","family":"Steinbusch","sequence":"additional","affiliation":[{"name":"Department of Cellular Neuroscience, Faculty of Health, Medicine & Life Sciences, Maastricht University, 6211 LK Maastricht, The Netherlands"},{"name":"Department of Cognitive Neuroscience, DGIST, Daegu 42988, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-2058","authenticated-orcid":false,"given":"Emanuel","family":"Vamanu","sequence":"additional","affiliation":[{"name":"Faculty of Biotechnology, The University of Agronomic Science and Veterinary Medicine, 59 Marasti blvd, 1 District, 011464 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-2078","authenticated-orcid":false,"given":"Ghulam","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia"},{"name":"Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-856X","authenticated-orcid":false,"given":"Mohan Prasad","family":"Singh","sequence":"additional","affiliation":[{"name":"Centre of Biotechnology, University of Allahabad, Prayagraj 211002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"nzz075","DOI":"10.1093\/cdn\/nzz075","article-title":"Public health aspects in the prevention and control of vitamin deficiencies","volume":"3","year":"2019","journal-title":"Curr. Dev. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/pgmj.2006.047670","article-title":"Micronutrients in health and disease","volume":"82","author":"Shenkin","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"ref_3","first-page":"7","article-title":"In eat for life: The food and nutrition board\u2019s guide to reducing your risk of chronic disease","volume":"19","author":"Woteki","year":"1993","journal-title":"Clin. Nutr. Insight"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1753-4887.2011.00469.x","article-title":"The nutrient problem","volume":"70","author":"Heaney","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1460-9","article-title":"Optimal nutrition and the ever- changing dietary landscape: A conference report","volume":"56","author":"Shao","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12937-016-0186-5","article-title":"The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: Current state","volume":"15","author":"Kurutas","year":"2015","journal-title":"Nutr. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1992.tb17085.x","article-title":"Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids","volume":"669","author":"Sies","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","first-page":"27","article-title":"Fat-soluble vitamins: Clinical indications and current challenges for chromatographic measurement","volume":"37","author":"Albahrani","year":"2016","journal-title":"Clin. Biochem. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.CSMR.0000306209.56939.48","article-title":"Water-soluble vitamins: Research update","volume":"4","author":"Bruno","year":"2005","journal-title":"Curr. Sports Med. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.mog.0000203870.22706.52","article-title":"Intestinal absorption of water-soluble vitamins: An update","volume":"22","author":"Said","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_11","unstructured":"Lykstad, J., and Sharma, S. (2021). Biochemistry, Water Soluble Vitamins, StatPearls."},{"key":"ref_12","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 1130, Thiamine, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thiamine."},{"key":"ref_13","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 493570, Riboflavin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Riboflavin."},{"key":"ref_14","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 938, Nicotinic Acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nicotinic-acid."},{"key":"ref_15","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 6613, Pantothenic Acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pantothenic-acid."},{"key":"ref_16","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 1054, Pyridoxine, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pyridoxine."},{"key":"ref_17","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 171548, Biotin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Biotin."},{"key":"ref_18","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 135398658, Folic Acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Folic-acid."},{"key":"ref_19","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 5311498, Cyanocobalamin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cyanocobalamin."},{"key":"ref_20","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 54670067, Ascorbic Acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ascorbic-acid."},{"key":"ref_21","first-page":"1","article-title":"Benefits of vitamins in the treatment of parkinson\u2019s disease","volume":"2019","author":"Zhao","year":"2019","journal-title":"Oxid. Med. Cell. Long."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kennedy, D.O. (2016). B vitamins and the brain: Mechanisms, dose and efficacy\u2014A review. Nutrients, 8.","DOI":"10.3390\/nu8020068"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.foodchem.2014.09.021","article-title":"Fat-soluble vitamin intestinal absorption: Absorption sites in the intestine and interactions for absorption","volume":"172","author":"Goncalves","year":"2015","journal-title":"Food Chem."},{"key":"ref_24","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 445354, Retinol, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Retinol."},{"key":"ref_25","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 5280795, Cholecalciferol, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cholecalciferol."},{"key":"ref_26","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 14985, Vitamin E, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Vitamin-E."},{"key":"ref_27","unstructured":"National Center for Biotechnology Information (2021, September 17). PubChem Compound Summary for CID 5280483, Vitamin K, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Vitamin-K."},{"key":"ref_28","first-page":"1153","article-title":"Prevalence and factors associated with fat-soluble vitamin deficiency in adolescents","volume":"35","author":"Tomiya","year":"2018","journal-title":"Nutr. Hosp. Organo Of. Soc. Esp. Nutr. Parenter. Y Enter."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Huang, Z., Liu, Y., Qi, G., Brand, D., and Zheng, S.G. (2018). Role of vitamin A in the immune system. J. Clin. Med., 7.","DOI":"10.3390\/jcm7090258"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.21.1.167","article-title":"Vitamin A, infection, and immune function","volume":"21","author":"Stephensen","year":"2001","journal-title":"Annu. Rev. Nutr."},{"key":"ref_32","unstructured":"Committee on Diet and Health, and National Research Council (1989). Diet and Health: Implications for Reducing Chronic Disease Risk, National Academies Press."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/biof.5520100202","article-title":"Lipid soluble vitamins in gene regulation","volume":"10","author":"Carlberg","year":"1999","journal-title":"Biofactors"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1476-5381.2009.00171.x","article-title":"Potential for vitamin D receptor agonists in the treatment of cardiovascular disease","volume":"158","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13167-017-0120-8","article-title":"Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases","volume":"8","author":"Koduah","year":"2017","journal-title":"EPMA J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fnagi.2017.00169","article-title":"Vitamin D, Homocysteine, and folate in subcortical vascular dementia and alzheimer dementia","volume":"9","author":"Moretti","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1191\/1352458502ms858oa","article-title":"Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis","volume":"8","author":"Royal","year":"2002","journal-title":"Mult. Scler. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14737175.2015.1008456","article-title":"Retinoic acid as a therapeutic option in Alzheimer\u2019s disease: A focus on cholinergic restoration","volume":"15","author":"Szutowicz","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2015.12.030","article-title":"Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies","volume":"1640","author":"Haar","year":"2016","journal-title":"Brain Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fnagi.2017.00421","article-title":"Mucuna pruriens protects against MPTP Intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u03baB\/pAKT signaling pathways","volume":"9","author":"Rai","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jchemneu.2017.06.005","article-title":"Immunomodulation of Parkinson\u2019s disease using Mucuna pruriens (Mp)","volume":"85","author":"Rai","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","article-title":"Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model","volume":"36","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s13205-020-02532-7","article-title":"Mucuna pruriens in Parkinson\u2019s and in some other diseases: Recent advancement and future prospective","volume":"10","author":"Rai","year":"2020","journal-title":"3 Biotech"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4103\/1673-5374.306066","article-title":"Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease","volume":"16","author":"Rai","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12312","article-title":"Parkinson\u2019s disease as a result of aging","volume":"14","author":"Rodriguez","year":"2015","journal-title":"Aging Cell"},{"key":"ref_46","first-page":"590","article-title":"Medical management of Parkinson\u2019s disease","volume":"33","author":"Goldenberg","year":"2008","journal-title":"Pharm. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease\u2014Repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6405278","article-title":"Role of diet and nutritional supplements in Parkinson\u2019s disease progression","volume":"2017","author":"Mischley","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ciulla, M., Marinelli, L., Cacciatore, I., and Stefano, A.D. (2019). Role of dietary supplements in the management of Parkinson\u2019s disease. Biomolecules, 9.","DOI":"10.3390\/biom9070271"},{"key":"ref_50","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"ref_51","first-page":"65","article-title":"What is vitamin A and why do we need it?","volume":"26","author":"Gilbert","year":"2013","journal-title":"Community Eye Health"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/S0007114510003260","article-title":"beta-Cryptoxanthin- and alpha-carotene-rich foods have greater apparent bioavailability than beta-carotene-rich foods in Western diets","volume":"105","author":"Burri","year":"2011","journal-title":"Br. J. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1194\/jlr.R030833","article-title":"Vitamin A and retinoid signaling: Genomic and nongenomic effects","volume":"54","author":"Piskunov","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00018-014-1815-9","article-title":"Retinoic acid signaling and neuronal differentiation","volume":"72","author":"Janesick","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/archneur.64.12.1706","article-title":"Functional implication of the vitamin A signaling pathway in the brain","volume":"64","author":"Tafti","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_56","first-page":"156","article-title":"Carotenoid, tocopherol, and retinol concentrations in elderly human brain","volume":"8","author":"Craft","year":"2004","journal-title":"J. Nutr. Health Aging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/mds.28173","article-title":"Dietary Antioxidants and Risk of Parkinson\u2019s Disease in the Singapore Chinese Health Study","volume":"35","author":"Ying","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/01.WNL.0000028688.75881.12","article-title":"Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk","volume":"59","author":"Zhang","year":"2002","journal-title":"Neurology"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Moretti, R., and Caruso, P. (2019). The controversial role of homocysteine in neurology: From labs to clinical practice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010231"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/14737175.8.6.957","article-title":"Role of homocysteine in the treatment of Parkinson\u2019s disease","volume":"8","year":"2008","journal-title":"Exp. Rev. Neurotherap."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","article-title":"Homocysteine and cognitive impairment in Parkinson\u2019s disease: A biochemical, neuroimaging, and genetic study","volume":"24","author":"Lage","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_62","first-page":"1","article-title":"Serum homocysteine level in parkinson\u2019s disease and its association with duration, cardinal manifestation, and severity of disease","volume":"2018","author":"Saadat","year":"2018","journal-title":"Park. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2007.01.028","article-title":"Homocysteine and Parkinson\u2019s disease: A dangerous liaison?","volume":"257","author":"Martignoni","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/1389202914666131210210559","article-title":"Homocysteine level and mechanisms of injury in Parkinson\u2019s disease as related to MTHFR, MTR, and MTHFD1 genes polymorphisms and Ldopa treatment","volume":"14","author":"Rozycka","year":"2013","journal-title":"Curr. Gen."},{"key":"ref_65","first-page":"5489057","article-title":"The impact of homocysteine, vitamin b12, and vitamin d levels on functional outcome after first-ever ischaemic stroke","volume":"2017","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12986-017-0233-z","article-title":"The metabolism and significance of homocysteine in nutrition and health","volume":"14","author":"Kumar","year":"2017","journal-title":"Nutr. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3164\/jcbn.17-56","article-title":"Association between vitamin B group supplementation with changes in % flow-mediated dilatation and plasma homocysteine levels: A randomized controlled trial","volume":"64","author":"Maruyama","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","article-title":"Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease","volume":"67","author":"Koudstaal","year":"2006","journal-title":"Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/nu7095333","article-title":"Associations between B Vitamins and Parkinson\u2019s Disease","volume":"7","author":"Shen","year":"2015","journal-title":"Nutrients"},{"key":"ref_70","first-page":"91","article-title":"Characterization of Vitamin B12 Supplementation and correlation with clinical outcomes in a large longitudinal study of early Parkinson\u2019s disease","volume":"12","author":"Dietiker","year":"2019","journal-title":"J. Mov. Dis."},{"key":"ref_71","first-page":"5","article-title":"Review: Power foods for the brain","volume":"2015","author":"Kennedy","year":"2015","journal-title":"Cerebrum"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cns.12078","article-title":"The beneficial role of thiamine in Parkinson disease","volume":"19","author":"Luong","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/1673-5374.179047","article-title":"An open-label pilot study with high-dose thiamine in Parkinson\u2019s disease","volume":"11","author":"Costantini","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ejcn.2016.181","article-title":"Intake of vitamin B before onset of Parkinson\u2019s disease and atypical parkinsonism and olfactory function at the time of diagnosis","volume":"71","author":"Johansson","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/138920211796429736","article-title":"The genetics of vitamin C loss in vertebrates","volume":"12","author":"Drouin","year":"2011","journal-title":"Curr. Genom."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10284150500484638","article-title":"Niacin improved rigidity and bradykinesia in a Parkinson\u2019s disease patient but also caused unacceptable nightmares and skin rash\u2014A case report","volume":"8","author":"Alisky","year":"2005","journal-title":"Nutr. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.1984.03350130016019","article-title":"Renal failure secondary to massive infusion of vitamin C","volume":"252","author":"McAllister","year":"1984","journal-title":"JAMA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1445-5994.1994.tb01477.x","article-title":"Acute oxalate nephropathy after a massive intravenous dose of vitamin C","volume":"24","author":"Wong","year":"1994","journal-title":"Aust. N. Z. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2741\/4160","article-title":"Effects of vitamin C on health: A review of evidence","volume":"18","author":"Grosso","year":"2013","journal-title":"Front. Biosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.wnf.0000150865.21759.bc","article-title":"The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease","volume":"27","author":"Nagayama","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-6606-6-16","article-title":"Roles of vitamin D in amyotrophic lateral sclerosis: Possible genetic and cellular signaling mechanisms","volume":"6","author":"Luong","year":"2013","journal-title":"Mol. Brain"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/derm.24494","article-title":"Sunlight and vitamin D: A global perspective for health","volume":"5","author":"Wacker","year":"2013","journal-title":"Dermato-Endocrinology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.31616\/asj.2018.12.6.1127","article-title":"The Role of vitamin D in the pathogenesis of adolescent idiopathic scoliosis","volume":"12","author":"Ng","year":"2018","journal-title":"Asian Spine J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu2050482","article-title":"The relationship between ultraviolet radiation exposure and vitamin D status","volume":"2","author":"Engelsen","year":"2010","journal-title":"Nutrients"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mds.26573","article-title":"Serum 25- hydroxyvitamin D concentrations in Mid-adulthood and Parkinson\u2019s disease risk","volume":"31","author":"Shrestha","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_86","first-page":"669","article-title":"The role of vitamin D in disease progression in early Parkinson\u2019s disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_87","first-page":"243","article-title":"Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes","volume":"7","author":"Brandi","year":"2010","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/TCRM.S3552","article-title":"The use of calcium and vitamin D in the management of osteoporosis","volume":"4","author":"Sunyecz","year":"2008","journal-title":"Therap. Clin. Risk Manag."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1589\/jpts.28.2204","article-title":"Bone mass and vitamin D levels in Parkinson\u2019s disease: Is there any difference between genders?","volume":"28","author":"Ozturk","year":"2016","journal-title":"J. Phys. Ther. Sci."},{"key":"ref_90","first-page":"29","article-title":"Systematic review of the relationship between vitamin D and Parkinson\u2019s disease","volume":"6","author":"Rimmelzwaan","year":"2016","journal-title":"J. Park. Dis."},{"key":"ref_91","first-page":"e2960","article-title":"The role of vitamin D in brain health: A mini literature review","volume":"10","author":"Anjum","year":"2018","journal-title":"Cureus"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fneur.2020.00454","article-title":"A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms","volume":"11","author":"Fullard","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/jnrp.jnrp_497_16","article-title":"Reversible Parkinsonism Due to Vitamin D Toxicity","volume":"8","author":"Chatterjee","year":"2017","journal-title":"J. Neurosci. Rural Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fneur.2018.00909","article-title":"Association between serum vitamin D levels and Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"9","author":"Luo","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40734-018-0074-6","article-title":"Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson\u2019s disease","volume":"5","author":"Luthra","year":"2018","journal-title":"J. Clin. Mov. Disord."},{"key":"ref_96","first-page":"e157","article-title":"The role of vitamin E in human health and some diseases","volume":"14","author":"Rizvi","year":"2014","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fneur.2019.00148","article-title":"Dietary vitamin E as a protective factor for Parkinson\u2019s disease: Clinical and experimental evidence","volume":"10","author":"Schirinzi","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","article-title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson\u2019s disease: A meta-analysis","volume":"4","author":"Etminan","year":"2005","journal-title":"Lancet Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.mam.2007.01.004","article-title":"Vitamin E and neurodegenerative diseases","volume":"28","author":"Ricciarelli","year":"2007","journal-title":"Mol. Aspects Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.410320722","article-title":"A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson\u2019s disease","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.50.6.1900","article-title":"Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group","volume":"50","author":"Vatassery","year":"1998","journal-title":"Neurology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/BF01294729","article-title":"Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson\u2019s disease","volume":"104","author":"Molina","year":"1997","journal-title":"J. Neural Transm."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1345\/aph.1G271","article-title":"Vitamin E supplementation in Alzheimer\u2019s disease, Parkinson\u2019s disease, tardive dyskinesia, and cataract: Part 2","volume":"39","author":"Pham","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7453\/gahmj.2013.096","article-title":"Is Ginkgo biloba and\/or a Multivitamin-multimineral supplement a therapeutic option for Parkinson\u2019s disease? A case report","volume":"3","author":"Conrad","year":"2014","journal-title":"Global Adv. Health Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fnhum.2019.00259","article-title":"Publication trends for Alzheimer\u2019s disease worldwide and in China: A 30-year bibliometric analysis","volume":"13","author":"Dong","year":"2019","journal-title":"Front. Human Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1073\/pnas.87.11.4265","article-title":"Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human","volume":"87","author":"MacDonald","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn2212","article-title":"Retinoic acid in the development, regeneration and maintenance of the nervous system","volume":"8","author":"Maden","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tins.2006.11.006","article-title":"Nur77 and retinoid X receptors: Crucial factors in dopamine-related neuroadaptation","volume":"30","author":"Levesque","year":"2007","journal-title":"Trends Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"14349","DOI":"10.1073\/pnas.94.26.14349","article-title":"Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor\u2013 retinoid X receptor family","volume":"94","author":"Samad","year":"1997","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnagi.2015.00020","article-title":"Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson\u2019s disease","volume":"7","author":"Esteves","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Yin, L.-H., Shen, H., Diaz-Ruiz, O., B\u00e4ckman, C.M., Bae, E., Yu, S.-J., and Wang, Y. (2012). Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson\u2019s disease. BMC Neurosci., 13.","DOI":"10.1186\/1471-2202-13-120"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuint.2019.02.002","article-title":"The effects of retinol oral supplementation in 6-hydroxydopamine dopaminergic denervation model in Wistar rats","volume":"125","author":"Kunzler","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/17425255.2020.1811232","article-title":"Retinoic acid receptor-targeted drugs in neurodegenerative disease","volume":"16","author":"Clark","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2015.05.024","article-title":"Neuroprotective effect of lycopene against MPTP induced experimental Parkinson\u2019s disease in mice","volume":"599","author":"Prema","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","article-title":"Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson\u2019s disease","volume":"36","author":"Kaur","year":"2011","journal-title":"Neurochem. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2891-2-7","article-title":"Vitamin C in human health and disease is still a mystery? An Overview","volume":"2","author":"Naidu","year":"2003","journal-title":"Nutr. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41598-018-22804-w","article-title":"Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson\u2019s Disease","volume":"8","author":"Tran","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Man Anh, H., Linh, D.M., My Dung, V., and Thi Phuong Thao, D. (2019). Evaluating dose-and time- dependent effects of vitamin c treatment on a parkinson\u2019s disease fly model. Parkinson\u2019s Dis., 2019.","DOI":"10.1155\/2019\/9720546"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0028-3908(85)90163-7","article-title":"Protection against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid","volume":"24","author":"Sershen","year":"1985","journal-title":"Neuropharmacology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","article-title":"Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson\u2019s Disease, Shifting M1 to M2 Microglia Responses","volume":"12","author":"Calvello","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12974-018-1266-6","article-title":"Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats","volume":"15","author":"Lima","year":"2018","journal-title":"J. Neuroinflam."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neulet.2005.01.053","article-title":"Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E","volume":"380","author":"Ueda","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1474-4422(03)00300-4","article-title":"Dietary vitamin E and Parkinson\u2019s disease: Something to chew on","volume":"2","author":"Olanow","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.bbadis.2014.04.008","article-title":"The estrogen receptor beta-PI3K\/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson\u2019s disease model","volume":"1842","author":"Nakaso","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(89)91530-8","article-title":"Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence","volume":"476","author":"Cadet","year":"1989","journal-title":"Brain Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5607\/en.2013.22.3.214","article-title":"Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study","volume":"22","author":"Sharma","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(00)03296-0","article-title":"Neuroprotective effect of vitamin E on the early model of Parkinson\u2019s disease in rat: Behavioral and histochemical evidence","volume":"892","author":"Roghani","year":"2001","journal-title":"Brain Res."},{"key":"ref_128","first-page":"435","article-title":"Behavioral alterations after unilateral 6- hydroxydopamine lesions of the striatum. Effect of alpha-tocopherol","volume":"53","author":"Heim","year":"2001","journal-title":"Pol. J. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neuropharm.2008.08.033","article-title":"Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism","volume":"55","author":"Abdin","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_130","first-page":"1","article-title":"Distinct retinoic acid receptor (RAR) isotypes control differentiation of embryonal carcinoma cells to dopaminergic or striatopallidal medium spiny neurons","volume":"7","author":"Sobska","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Giri, B., Belanger, K., Seamon, M., Bradley, E., Purohit, S., Chong, R., Morgan, J.C., Baban, B., and Wakade, C. (2019). Niacin Ameliorates Neuro-Inflammation in Parkinson\u2019s Disease via GPR109A. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184559"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<95::AID-SYN2>3.0.CO;2-U","article-title":"Effects of NADH on dopamine release in rat striatum","volume":"36","author":"Pearl","year":"2000","journal-title":"Synapse"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00129-3","article-title":"Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH","volume":"244","author":"Seitz","year":"1998","journal-title":"Neurosci. Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mds.870080305","article-title":"Ascorbic acid protects against levodopa- induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line","volume":"8","author":"Pardo","year":"1993","journal-title":"Mov. Disord."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/etm.2014.1842","article-title":"Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson\u2019s disease","volume":"8","author":"Lu","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","article-title":"Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats","volume":"904","author":"Wang","year":"2001","journal-title":"Brain Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3988\/jcn.2006.2.4.252","article-title":"1alpha,25-Dihydroxyvitamin D(3) Protects Dopaminergic Neurons in Rodent Models of Parkinson\u2019s Disease through Inhibition of Microglial Activation","volume":"2","author":"Kim","year":"2006","journal-title":"J. Clin. Neurol."},{"key":"ref_138","first-page":"a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Frosch","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegen."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-170163","article-title":"Neurofibrillary tangles of A\u03b2 x- 40 in Alzheimer\u2019s disease brains","volume":"58","author":"Lacosta","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-006-0071-y","article-title":"Neuropathology of Alzheimer disease: Pathognomonic but not pathogenic","volume":"111","author":"Castellani","year":"2006","journal-title":"Acta Neuropathol."},{"key":"ref_142","first-page":"1105","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"Trushina","year":"2017","journal-title":"J. Alz. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fphar.2018.01162","article-title":"Antioxidant and oxidative stress: A mutual interplay in age-related diseases","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnagi.2020.00255","article-title":"Nicotinamide, a Poly [ADP-Ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer\u2019s disease","volume":"12","author":"Salech","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_145","first-page":"416","article-title":"Lower brain and blood nutrient status in Alzheimer\u2019s disease: Results from meta-analyses","volume":"3","author":"Vellas","year":"2017","journal-title":"Alz. Dement."},{"key":"ref_146","first-page":"OE07","article-title":"Vitamin supplementation as an adjuvant treatment for Alzheimer\u2019s disease","volume":"10","author":"Bhatti","year":"2016","journal-title":"J. Clin. Diag. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","article-title":"Plasma nutrient status of patients with Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"10","author":"Vellas","year":"2014","journal-title":"Alz. Dement."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/qjmed\/92.1.39","article-title":"Plasma chain-breaking antioxidants in Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease","volume":"92","author":"Foy","year":"1999","journal-title":"QJM"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Lloret, A., Esteve, D., Monllor, P., Cervera-Ferri, A., and Lloret, A. (2019). The effectiveness of vitamin E treatment in Alzheimer\u2019s disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040879"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.61.1.82","article-title":"Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The cache county study","volume":"61","author":"Zandi","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/jn\/nxaa087","article-title":"Long-term intake of dietary carotenoids is positively associated with late-life subjective cognitive function in a prospective study in US women","volume":"150","author":"Yuan","year":"2020","journal-title":"J. Nutr."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1567205016666190321163705","article-title":"Retinoic Acid and the Gut Microbiota in Alzheimer\u2019s Disease: Fighting Back-to-Back?","volume":"16","author":"Endres","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-180682","article-title":"Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer\u2019s Disease and Not Associated with Cognitive Decline or Incident Dementia","volume":"67","author":"Ishii","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-nutr-122319-034227","article-title":"Vitamin A and Retinoic Acid in Cognition and Cognitive Disease","volume":"40","author":"Kouchmeshky","year":"2020","journal-title":"Annu. Rev. Nutr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0165-6147(90)90148-2","article-title":"Clinical significance of pharmacological modulation of homocysteine metabolism","volume":"11","author":"Refsum","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fnagi.2018.00350","article-title":"Hyperhomocysteinemia as a risk factor for vascular contributions to cognitive impairment and dementia","volume":"10","author":"Price","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-2006-9409","article-title":"Thoughts on B-vitamins and dementia","volume":"9","author":"Morris","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine- lowering B- vitamin treatment in mild cognitive impairment: A randomized controlled trial","volume":"27","author":"Oulhaj","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/JAD-2012-111739","article-title":"Effect of homocysteine lowering treatment on cognitive function: A systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Ford","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40266-019-00649-w","article-title":"Effect of vitamin B supplementation on cognitive function in the elderly: A systematic review and meta-analysis","volume":"36","author":"Ford","year":"2019","journal-title":"Drugs Aging"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjmed.2010.01.017","article-title":"Effect of folic acid, with or without other B vitamins, on cognitive decline: Meta-analysis of randomized trials","volume":"123","author":"Wald","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.clinthera.2007.10.012","article-title":"Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer\u2019s disease: A 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients","volume":"29","author":"Sun","year":"2007","journal-title":"Clin. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.clnu.2019.11.005","article-title":"Randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients","volume":"39","author":"Kwok","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1212\/WNL.0000000000001050","article-title":"Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT","volume":"83","author":"Enneman","year":"2014","journal-title":"Neurology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e17970","DOI":"10.1097\/MD.0000000000017970","article-title":"The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China: A cross-sectional study","volume":"47","author":"Meng","year":"2019","journal-title":"Medicine"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3906\/sag-1406-136","article-title":"Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease","volume":"45","author":"Ulusu","year":"2015","journal-title":"Turk. J. Med. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1533317511432736","article-title":"Role of thiamine in Alzheimer\u2019s disease","volume":"26","year":"2011","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0891988704272308","article-title":"Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects","volume":"18","author":"Osimani","year":"2005","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1021\/acschemneuro.7b00230","article-title":"Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau","volume":"8","author":"Rafiee","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_173","first-page":"40","article-title":"Levels of vitamins and homocysteine in older adults with Alzheimer disease or mild cognitive impairment in cuba","volume":"2","year":"2020","journal-title":"MEDICC Rev."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Hama, Y., Hamano, T., Shirafuji, N., Hayashi, K., Ueno, A., Enomoto, S., Nagata, M., Kimura, H., Matsunaga, A., and Ikawa, M. (2020). Influences of folate supplementation on homocysteine and cognition in patients with folate deficiency and cognitive impairment. Nutrients, 12.","DOI":"10.3390\/nu12103138"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"5912146","DOI":"10.1155\/2016\/5912146","article-title":"Folic acid supplementation mitigates Alzheimer\u2019s disease by reducing inflammation: A randomized controlled trial","volume":"2016","author":"Chen","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"ref_177","first-page":"192747","article-title":"Vitamin D and Alzheimer\u2019s disease: Neurocognition to therapeutics","volume":"2015","author":"Banerjee","year":"2015","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/1078-0432.CCR-04-1968","article-title":"Vitamin D3 metabolism in human glioblastoma multiforme: Functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol","volume":"11","author":"Diesel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/joim.12308","article-title":"Vitamin D and brain health: The need for vitamin D supplementation and sensible sun exposure","volume":"277","author":"Holick","year":"2015","journal-title":"J. Int. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jnr.490380212","article-title":"Synthesis of 1, 25- dihydroxyvitamin D3 by rat brain macrophages in vitro","volume":"38","author":"Neveu","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00303-3","article-title":"1, 25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons","volume":"343","author":"Brown","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Orme, R.P., Bhangal, M.S., and Fricker, R.A. (2013). Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062040"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14336\/AD.2015.0825","article-title":"The involvement of BDNF, NGF and GDNF in aging and Alzheimer\u2019s disease","volume":"6","author":"Budni","year":"2015","journal-title":"Aging Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/157015911798376190","article-title":"The neurotrophins and their role in Alzheimer\u2019s disease","volume":"9","author":"Allen","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dneu.20759","article-title":"Nerve growth factor as a paradigm of neurotrophins related to Alzheimer\u2019s disease","volume":"70","author":"Calissano","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/bi972965+","article-title":"An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts","volume":"37","author":"Veenstra","year":"1998","journal-title":"Biochemistry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e21371","DOI":"10.1097\/MD.0000000000021371","article-title":"Association between Vitamin B12 levels and cognitive function in the elderly Korean population","volume":"99","author":"Soh","year":"2020","journal-title":"Medicine"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.3390\/nu6125453","article-title":"Effects of vitamin E on cognitive performance during ageing and in Alzheimer\u2019s disease","volume":"6","author":"Weber","year":"2014","journal-title":"Nutrients"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/CIA.S186760","article-title":"Vitamin E and Alzheimer\u2019s disease: What do we know so far?","volume":"14","author":"Browne","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Bramanti, P., and Mazzon, E. (2017). Role of vitamin E in the treatment of Alzheimer\u2019s disease: Evidence from animal models. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122504"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-190249","article-title":"Association between cognitive impairment and vitamin B12, folate, and homocysteine status in elderly adults: A retrospective study","volume":"70","author":"Baroni","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: The TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Hira, S., Saleem, U., Anwar, F., Sohail, M.F., Raza, Z., and Ahmad, B. (2019). \u03b2-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer\u2019s Disease. Biomolecules, 9.","DOI":"10.3390\/biom9090441"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1447-0594.2011.00786.x","article-title":"Vitamin A and Alzheimer\u2019s disease","volume":"12","author":"Ono","year":"2012","journal-title":"Ger. Gerontol. Int."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-2011-110455","article-title":"Vitamin A has anti-oligomerization effects on amyloid-beta in vitro","volume":"27","author":"Takasaki","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JAD-2011-101971","article-title":"Vitamin C restores behavioral deficits and amyloid-\u03b2 oligomerization without affecting plaque formation in a mouse model of Alzheimer\u2019s disease","volume":"26","author":"Murakami","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e000086","DOI":"10.15419\/jmri.86","article-title":"ACE Alzheimer\u2019s: The role of vitamin A, C and E (ACE) in oxidative stress induced Alzheimer\u2019s disease","volume":"2","author":"Mehta","year":"2018","journal-title":"J. Med. Res. Innov."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.18632\/aging.102970","article-title":"Intranasal delivery of 9-cis retinoic acid reduces beta-amyloid deposition via inhibiting astrocyte-mediated inflammation","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4103\/1673-5374.259604","article-title":"Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","volume":"14","author":"Das","year":"2019","journal-title":"Neural Regen. Res."},{"key":"ref_201","first-page":"118","article-title":"Dementia: What pharmacists need to know","volume":"150","author":"Duong","year":"2017","journal-title":"Can. Pharm. J.\/Rev. Pharm. Can."},{"key":"ref_202","first-page":"79","article-title":"Dementia","volume":"84","author":"Cunningham","year":"2015","journal-title":"Ulster Med. J."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.13031","article-title":"Vitamin B1 (thiamine) and dementia","volume":"1367","author":"Gibson","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10072-010-0419-x","article-title":"Vitamin B12 deficiency associated with symptoms of frontotemporal dementia","volume":"32","author":"Blundo","year":"2011","journal-title":"Neurol. Sci."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1515\/CCLM.2004.208","article-title":"Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease","volume":"42","author":"Malaguarnera","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2004.01959.x","article-title":"Pellagra: Dermatitis, dementia, and diarrhea","volume":"43","author":"Hegyi","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.intimp.2018.10.020","article-title":"Vitamin C alleviates LPS-induced cognitive impairment in mice by suppressing neuroinflammation and oxidative stress","volume":"65","author":"Zhang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.etap.2017.02.010","article-title":"Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer\u2019s disease","volume":"50","author":"Olajide","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12031-016-0817-5","article-title":"Dual Role of Vitamin C on the Neuroinflammation Mediated Neurodegeneration and Memory Impairments in Colchicine Induced Rat Model of Alzheimer Disease","volume":"60","author":"Sil","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10787-017-0372-x","article-title":"Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer\u2019s disease","volume":"26","author":"Yamini","year":"2018","journal-title":"Inflammopharmacology"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1742-2094-9-244","article-title":"Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden","volume":"9","author":"Briones","year":"2012","journal-title":"J. Neuroinflam."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"108586","DOI":"10.1016\/j.steroids.2020.108586","article-title":"Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer\u2019s disease in rats by targeting Keap1\/Nrf2 and MAPK-38p\/ERK signaling pathways","volume":"156","author":"Rashed","year":"2020","journal-title":"Steroids"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/labmed\/lmaa066","article-title":"Comparison of Serum Free and Bioavailable 25- Hydroxyvitamin D Levels in Alzheimer\u2019s Disease and Healthy Control Patients","volume":"52","author":"Ertilav","year":"2020","journal-title":"Lab. Med."},{"key":"ref_214","first-page":"104893","article-title":"Vitamin D Exerts Neuroprotection via SIRT1\/Nrf-2\/ NF-kB Signaling Pathways against D-Galactose-induced Memory Impairment in Adult Mice","volume":"4","author":"Ali","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.freeradbiomed.2020.10.007","article-title":"Vitamin D deficiency exacerbates Alzheimer-like pathologies by reducing antioxidant capacity","volume":"161","author":"Fan","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_216","first-page":"182","article-title":"Vitamin E family: Role in the pathogenesis and treatment of Alzheimer\u2019s disease","volume":"2","author":"Boccardi","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-160329","article-title":"Multi-vitamin B supplementation reverses hypoxia-induced tau hyperphosphorylation and improves memory function in adult mice","volume":"54","author":"Yu","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_219","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., and Amemiya, A. (2021, September 17). Huntington Disease, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk1305\/."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","article-title":"Huntington disease: Pathogenesis and treatment","volume":"33","author":"Dayalu","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4161\/derm.26135","article-title":"High prevalence of vitamin D deficiency and insufficiency in patients with manifest Huntington disease: An explorative study","volume":"5","author":"Chel","year":"2013","journal-title":"Dermato Endocrinol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Patassini, S., Begley, P., Xu, J., Church, S.J., Kureishy, N., Reid, S.J., Waldvogel, H.J., Faull, R.L., Snell, R.G., and Unwin, R.D. (2019). Cerebral vitamin B5 (D-Pantothenic Acid) deficiency as a potential cause of metabolic perturbation and neurodegeneration in Huntington\u2019s disease. Metabolites, 9.","DOI":"10.3390\/metabo9060113"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington\u2019s disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_226","first-page":"87","article-title":"The involvement of retinoic acid in the development of the vertebrate central nervous system","volume":"113","author":"Maden","year":"1991","journal-title":"Dev. Suppl."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-150450","article-title":"Molecular signaling mechanisms of natural and synthetic retinoids for inhibition of pathogenesis in Alzheimer\u2019s disease","volume":"50","author":"Chakrabarti","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pneurobio.2005.03.002","article-title":"Role of retinoid signalling in the adult brain","volume":"75","author":"Lane","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1586\/ern.09.86","article-title":"All-trans retinoic acid as a novel therapeutic strategy for Alzheimer\u2019s disease","volume":"9","author":"Lee","year":"2009","journal-title":"Exp. Rev. Neurotherap."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s12035-016-0010-4","article-title":"Genome-wide analysis of RAR\u03b2 transcriptional targets in mouse striatum links retinoic acid signaling with Huntington\u2019s disease and other neurodegenerative disorders","volume":"54","author":"Ye","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1523\/JNEUROSCI.1278-15.2015","article-title":"Retinoic acid receptor \u03b2 controls development of striatonigral projection neurons through FGF-dependent and Meis1- dependent mechanisms","volume":"35","author":"Paschaki","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-pharmtox-010818-021807","article-title":"Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation","volume":"59","author":"Moutinho","year":"2019","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1007\/s12035-016-0079-9","article-title":"Thiamine deficiency and neurodegeneration: The interplay among oxidative stress, endoplasmic reticulum stress, and autophagy","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"109252","DOI":"10.1016\/j.mehy.2019.109252","article-title":"Thiamin and protein folding","volume":"129","author":"Lonsdale","year":"2019","journal-title":"Med. Hypotheses"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.taap.2017.02.009","article-title":"Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells","volume":"320","author":"Wang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"751","DOI":"10.17219\/acem\/63091","article-title":"Role of thiamine in Huntington\u2019s disease pathogenesis: In vitro studies","volume":"26","author":"Bubko","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","article-title":"Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington\u2019s disease: Implication of oxidative stress- poly (ADP- ribose) polymerase pathway","volume":"33","author":"Sidhu","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2014.07.077","article-title":"Postural stability limits in manifest and premanifest Huntington\u2019s disease under different sensory conditions","volume":"279","author":"Blanchet","year":"2014","journal-title":"Neuroscience"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-170149","article-title":"Motor phenotype in neurodegenerative disorders: Gait and balance platform study design protocol for the ontario neurodegenerative research initiative (ONDRI)","volume":"59","author":"Bartha","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"3975417","DOI":"10.1155\/2017\/3975417","article-title":"Body posture, postural stability, and metabolic age in patients with Parkinson\u2019s disease","volume":"2017","author":"Wilczynski","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jbmr.2709","article-title":"The roles and mechanisms of actions of vitamin C in bone: New developments","volume":"30","author":"Aghajanian","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00001756-200307010-00015","article-title":"Ascorbate treatment attenuates the Huntington behavioral phenotype in mice","volume":"14","author":"Rebec","year":"2003","journal-title":"Neuroreport"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Mahmoud, S., Gharagozloo, M., Simard, C., and Gris, D. (2019). Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells, 8.","DOI":"10.3390\/cells8020184"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1089\/ars.2013.5387","article-title":"Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington\u2019s disease","volume":"19","author":"Rebec","year":"2013","journal-title":"Antiox. Redox Sig."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2009.07.019","article-title":"Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6\/2 mouse model of Huntington\u2019s disease","volume":"1290","author":"Dorner","year":"2009","journal-title":"Brain Res."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/2230-8210.93732","article-title":"Rickets\u2013vitamin D deficiency and dependency","volume":"16","author":"Sahay","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2040622310381934","article-title":"Effects of vitamin d on muscle function and performance: A review of evidence from randomized controlled trials","volume":"2","author":"Rejnmark","year":"2011","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"176","DOI":"10.21307\/ane-2017-017","article-title":"High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington\u2019s disease transgenic mice","volume":"76","author":"Molnar","year":"2016","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1176\/ajp.152.12.1771","article-title":"Trial of d-!a-tocopherol in Huntington\u2019s disease","volume":"152","author":"Peyser","year":"1995","journal-title":"Am. J. Psychiatry."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington\u2019s disease","volume":"48","author":"Liptaj","year":"2006","journal-title":"Neurochem. Int."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/157015910792246218","article-title":"Chronic progressive multiple sclerosis-pathogenesis of neurodegeneration and therapeutic strategies","volume":"8","author":"Fitzner","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Correale, J., Marrodan, M., and Ysrraelit, M.C. (2019). Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines, 7.","DOI":"10.3390\/biomedicines7010014"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: Molecular mechanisms and therapeutic opportunities","volume":"19","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fneur.2018.00031","article-title":"Eye movement abnormalities in multiple sclerosis: Pathogenesis, modeling, and treatment","volume":"9","author":"Serra","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis\u2014A review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.expneurol.2013.08.002","article-title":"Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage","volume":"249","author":"Adzemovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jamaneurol.2015.4800","article-title":"Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort","volume":"73","author":"Munger","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","article-title":"Vitamin D as an immune modulator in multiple sclerosis, a review","volume":"194","author":"Smolders","year":"2008","journal-title":"J. Neuroimmun."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and multiple sclerosis: A comprehensive review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol. Ther."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.20316","article-title":"Vitamin E intake and risk of amyotrophic lateral sclerosis","volume":"57","author":"Ascherio","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/092986708783503159","article-title":"Therapeutic potential of vitamin D for multiple sclerosis","volume":"15","author":"Niino","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: Risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/1352458515606986","article-title":"Vitamin D and axonal injury in multiple sclerosis","volume":"22","author":"Sandberg","year":"2016","journal-title":"Mult. Scler. J."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00702-019-02093-x","article-title":"Vitamin D rise enhances blood perfusion in patients with multiple sclerosis","volume":"126","author":"Muller","year":"2019","journal-title":"J. Neural Transm."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Perga, S., Albo, A.G., Lis, K., Minari, N., Falvo, S., Marnetto, F., Caldano, M., Reviglione, R., Berchialla, P., and Capobianco, M.A. (2015). Vitamin D binding protein isoforms and apolipoprotein E in cerebrospinal fluid as prognostic biomarkers of multiple sclerosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129291"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-010-5797-8","article-title":"The emerging role of vitamin D binding protein in multiple sclerosis","volume":"258","author":"Disanto","year":"2011","journal-title":"J. Neurol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1352458513500552","article-title":"Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis","volume":"20","author":"Smolders","year":"2014","journal-title":"Mult. Scler. J."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-014-0148-4","article-title":"The evidence for a beneficial role of vitamin A in multiple sclerosis","volume":"28","author":"Fragoso","year":"2014","journal-title":"CNS Drugs"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ensci.2018.01.007","article-title":"A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis","volume":"10","author":"Rousta","year":"2018","journal-title":"eNeurologicalsci"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ane.12045","article-title":"Fat-soluble vitamins as disease modulators in multiple sclerosis","volume":"127","author":"Torkildsen","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0306-9877(84)90046-X","article-title":"The increased prevalence of multiple sclerosis among people who were born and bred in areas where goitre is endemic","volume":"14","author":"Warren","year":"1984","journal-title":"Med. Hypotheses"},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Miller, E.D., Dziedzic, A., Saluk-Bijak, J., and Bijak, M. (2019). A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis. Nutrients, 11.","DOI":"10.3390\/nu11071528"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0976-3147.102609","article-title":"The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"3","author":"Jafarirad","year":"2012","journal-title":"J. Neurosci. Rural Pract."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1352458512457843","article-title":"Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis","volume":"19","author":"Myhr","year":"2013","journal-title":"Mult. Scler. J."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-014-1335-6","article-title":"Astrocyte-derived retinoic acid: A novel regulator of blood\u2013brain barrier function in multiple sclerosis","volume":"128","author":"Mizee","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458512472752","article-title":"Vitamin A and systemic inflammation as protective factors in multiple sclerosis","volume":"19","author":"Salzer","year":"2013","journal-title":"Mult. Scler. J."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.msard.2013.06.011","article-title":"Vitamin A is not associated with exacerbations in multiple sclerosis","volume":"3","author":"Runia","year":"2014","journal-title":"Mult. Scler. Rel. Dis."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2018.0611","article-title":"Use of vitamins and dietary supplements by patients with multiple sclerosis: A review","volume":"75","author":"Evans","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10284150290029205","article-title":"Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis","volume":"5","author":"Besler","year":"2002","journal-title":"Nutr. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12640-015-9584-2","article-title":"Evaluation of delta-aminolevulinic dehydratase activity, oxidative stress biomarkers, and vitamin D levels in patients with multiple sclerosis","volume":"29","author":"Polachini","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_282","first-page":"167156","article-title":"Serum metabolic profile in multiple sclerosis patients","volume":"2011","author":"Tavazzi","year":"2011","journal-title":"Mult. Scler. Int."},{"key":"ref_283","first-page":"83","article-title":"Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats","volume":"5","author":"Babri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"ref_284","first-page":"413465","article-title":"Initial immunopathogenesis of multiple sclerosis: Innate immune response","volume":"2013","author":"Pineda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.57.1.75","article-title":"Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women","volume":"57","author":"Zhang","year":"2001","journal-title":"Neurology"},{"key":"ref_286","first-page":"286","article-title":"Vitamin B12 deficiency and multiple sclerosis; is there any association?","volume":"3","author":"Najafi","year":"2012","journal-title":"Int. J. Prev. Med."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.clineuro.2013.05.007","article-title":"Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: A case control study","volume":"115","author":"Moghaddasi","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.1992.00530300089014","article-title":"Vitamin B12 metabolism in multiple sclerosis","volume":"49","author":"Reynolds","year":"1992","journal-title":"Arch. Neurol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.1991.00530200044017","article-title":"Multiple sclerosis associated with vitamin B12 deficiency","volume":"48","author":"Reynolds","year":"1991","journal-title":"Arch. Neurol."},{"key":"ref_291","first-page":"1271","article-title":"Null association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine","volume":"12","author":"Weinstein","year":"2003","journal-title":"Cancer Epid. Prev. Biomark."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41582-020-0331-9","article-title":"Vitamin B3 promotes remyelination","volume":"16","author":"Lempriere","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"bcr2013009144","DOI":"10.1136\/bcr-2013-009144","article-title":"High dose thiamine improves fatigue in multiple sclerosis","volume":"2013","author":"Costantini","year":"2013","journal-title":"BMJ Case Rep."},{"key":"ref_294","first-page":"435","article-title":"Impact of vitamin A supplementation on disease progression in patients with multiple sclerosis","volume":"18","author":"Bitarafan","year":"2015","journal-title":"Arch. Iran Med."},{"key":"ref_295","doi-asserted-by":"crossref","unstructured":"Loken-Amsrud, K.I., Myhr, K.M., Bakke, S.J., Beiske, A.G., Bjerve, K.S., Bjornara, B.T., Hovdal, H., Lilleas, F., Midgard, R., and Pedersen, T. (2013). Alpha-tocopherol and MRI outcomes in multiple sclerosis\u2014Association and prediction. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054417"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jnnp.2009.188151","article-title":"Motor neuron disease: The bare essentials","volume":"9","author":"Talbot","year":"2009","journal-title":"Pract. Neurol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"371","DOI":"10.12688\/f1000research.10476.1","article-title":"What causes amyotrophic lateral sclerosis?","volume":"6","author":"Martin","year":"2017","journal-title":"F1000Research"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"ref_299","first-page":"14S","article-title":"Vitamin D levels in serum of amyotrophic lateral sclerosis patients. (P2. 069)","volume":"84","author":"Cortese","year":"2015","journal-title":"AAN Enterp."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","article-title":"Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis","volume":"35","author":"Camu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1755-5949.2012.00316.x","article-title":"Dietary vitamin D3 supplementation at 10\u00d7 the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study","volume":"18","author":"Gianforcaro","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Gianforcaro, A., Solomon, J.A., and Hamadeh, M.J. (2013). Vitamin D(3) at 50\u00d7 AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0030243"},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Solomon, J.A., Gianforcaro, A., and Hamadeh, M.J. (2011). Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029354"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"35","DOI":"10.11138\/FNeur\/2017.32.1.035","article-title":"Vitamin D in amyotrophic lateral sclerosis","volume":"32","author":"Libonati","year":"2017","journal-title":"Funct. Neurol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Chiricosta, L., Gugliandolo, A., Tardiolo, G., Bramanti, P., and Mazzon, E. (2019). Transcriptomic analysis of MAPK signaling in NSC-34 motor neurons treated with vitamin E. Nutrients, 11.","DOI":"10.3390\/nu11051081"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmed.2010.09.001","article-title":"The intricate mechanisms of neurodegeneration in prion diseases","volume":"17","author":"Soto","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2174\/156652409789105543","article-title":"Prion protein misfolding","volume":"9","author":"Kupfer","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/19336896.2015.1110293","article-title":"Prion protein scrapie and the normal cellular prion protein","volume":"10","author":"Atkinson","year":"2016","journal-title":"Prion"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fnmol.2019.00169","article-title":"Recent Advances in Understanding Mammalian Prion Structure: A Mini Review","volume":"12","author":"Terry","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_311","first-page":"1612","article-title":"Prion diseases","volume":"21","author":"Geschwind","year":"2015","journal-title":"Continuum"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.jmb.2014.09.017","article-title":"Structural determinants in prion protein folding and stability","volume":"426","author":"Benetti","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1874609812666190111100205","article-title":"Oxidative and inflammatory events in prion diseases: Can they be therapeutic targets?","volume":"11","author":"Prasad","year":"2019","journal-title":"Curr. Aging Sci."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/ars.2009.2628","article-title":"Redox control of prion and disease pathogenesis","volume":"12","author":"Singh","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3390\/nu5114521","article-title":"Cobalamin deficiency: Clinical picture and radiological findings","volume":"5","author":"Briani","year":"2013","journal-title":"Nutrients"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.13207","article-title":"B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin","volume":"26","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_317","doi-asserted-by":"crossref","unstructured":"Rzepka, Z., Respondek, M., Pawlik, J., Beberok, A., Gryko, D., and Wrze\u015bniok, D. (2019). Cobalamin deficiency: Effect on homeostasis of cultured human astrocytes. Cells, 8.","DOI":"10.3390\/cells8121505"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pneurobio.2009.04.004","article-title":"The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency","volume":"88","author":"Scalabrino","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1096\/fasebj.13.14.2083","article-title":"Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B(12) (cobalamin) in the rat central nervous system","volume":"13","author":"Scalabrino","year":"1999","journal-title":"FASEB J."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biochi.2013.01.002","article-title":"Cobalamin and normal prions: A new horizon for cobalamin neurotrophism","volume":"95","author":"Scalabrino","year":"2013","journal-title":"Biochimie"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4161\/pri.25739","article-title":"Vitamin D2 interacts with Human PrPc (90\u2013231) and breaks PrPc oligomerization in vitro","volume":"7","author":"Suenaga","year":"2013","journal-title":"Prion"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ccr.2009.05.011","article-title":"Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)","volume":"253","author":"Kozlowski","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnins.2017.00003","article-title":"Metal dyshomeostasis and their pathological role in prion and prion-like diseases: The basis for a nutritional approach","volume":"11","author":"Toni","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Aridi, Y.S., Walker, J.L., and Wright, O.R. (2017). The association between the Mediterranean dietary pattern and cognitive health: A systematic review. Nutrients, 9.","DOI":"10.3390\/nu9070674"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/nutrit\/nuv005","article-title":"Dietary modification and supplementation for the treatment of age-related macular degeneration","volume":"73","author":"Broadhead","year":"2015","journal-title":"Nutr. Rev."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lute-in\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cbf.3167","article-title":"Protection against oxidative stress by vitamin D in cone cells","volume":"34","author":"Tohari","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1167\/iovs.14-14763","article-title":"Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a repre-sentative Korean population","volume":"55","author":"Kim","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Di Somma, C., Scarano, E., Barrea, L., Zhukouskaya, V.V., Savastano, S., Mele, C., Scacchi, M., Aimaretti, G., Colao, A., and Marzullo, P. (2017). Vitamin D and neurological diseases: An endocrine view. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112482"},{"key":"ref_330","first-page":"1178646918776658","article-title":"The influence of nicotinamide on health and disease in the central nervous system","volume":"11","author":"Fricker","year":"2018","journal-title":"Int. J. Trypt. Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1284\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:03Z","timestamp":1760166183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":330,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101284"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101284","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}